(RTTNews) - For the first six months of the year, the company reported GAAP net income of $2.29 billion or $2.23 per share, compared to $2.01 billion or $1.85 per share for the same period last year.

Adjusted net income for the first-half was $2.43 billion or $2.37 per share, compared to $2.45 billion or $2.26 per share in the prior year period.

Revenue for the first-half fell to $7.02 billion from $7.38 billion in the corresponding year-ago period.

Looking forward, the company raised its full year adjusted earnings guidance to a range of $4.80 to $4.95 per share from its prior guidance of $4.55 to $4.75 per share.

The company also said revenue for 2009 was trending towards the upper end of its guidance range of $14.4 to $14.8 billion.
Analysts currently expect the company to earn $4.57 per share on revenue of $14.33 billion for the full year 2009.

Amgen shares, which have trade in a range of $44.96 to $66.51 over the past year, closed Monday's regular trading session at $60.77, down 15 cents. The stock is currently gaining $2.04 or 3.36% in after hours trading.

Click here to receive FREE breaking news email alerts for Amgen Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: contact editorial@rttnews.com

 Previous Page   1   2   3